M Holdings Securities’s Teva Pharmaceuticals TEVA Stock Holding History

M Holdings Securities’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$504K	Buy	15,925 +27	+0.2%	+$869	0.03%	252
2025 Q4	$496K	Buy	15,898 +4,180	+36%	+$103K	0.04%	248
2025 Q3	$237K	Buy	+11,718	New	+$206K	0.05%	87
2021 Q2	–	Sell	-13,167	Closed	-$152K	–	447
2021 Q1	$152K	Buy	+13,167	New	+$151K	0.01%	476
2018 Q1	–	Sell	-13,050	Closed	-$247K	–	337
2017 Q4	$247K	Sell	13,050 -15,232	-54%	-$229K	0.07%	269
2017 Q3	$498K	Buy	28,282 +5,425	+24%	+$122K	0.16%	180
2017 Q2	$759K	Buy	22,857 +4,403	+24%	+$136K	0.26%	106
2017 Q1	$592K	Buy	18,454 +4,902	+36%	+$167K	0.23%	124
2016 Q4	$491K	Buy	+13,552	New	+$541K	0.17%	137
2014 Q4	–	Sell	-1,020	Closed	-$24K	–	409
2014 Q3	$24K	Buy	+1,020	New	+$54K	0.01%	495

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

M Holdings Securities's TEVA Position: Q1 2026 in Review

M Holdings Securities increased its Teva Pharmaceuticals (TEVA) stake by 0.17% in Q1 2026, buying an estimated $869 and bringing the position to 15,925 shares worth $504K. The position accounts for 0.03% of the portfolio, ranked #252.

M Holdings Securities first reported a position in TEVA in Q3 2014 and has held it in 10 quarters since. The position peaked at $759K in Q2 2017. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

M Holdings Securities held 15,925 shares of Teva Pharmaceuticals worth $504K as of Q1 2026.
M Holdings Securities bought 27 Teva Pharmaceuticals shares in Q1 2026, an estimated $869.
Teva Pharmaceuticals made up 0.03% of M Holdings Securities's portfolio in Q1 2026, its #252 holding.
M Holdings Securities first reported a position in Teva Pharmaceuticals in Q3 2014 and has held it in 10 quarters since.
M Holdings Securities's Teva Pharmaceuticals position peaked at $759K in Q2 2017.
650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on M Holdings Securities's 13F filing for Q1 2026, filed 12 May 2026.